Advanced Enzyme Technologies Ltd Share Price – NSE  / BSE

Pharmaceuticals, Small Cap

Total expenditure for the period under review added up to Rs 135.27 crore, up 19.2% YoY. This was primarily due to higher raw material costs (up 24.8% YoY), higher employee expenses (up 10.8% YoY) and higher other expenses (up 14.3% YoY).

Profit before tax in Q2 FY26 stood at Rs 59.54 crore, up by 41% from Rs 42.21 crore recorded in Q2 FY25.

Advanced Enzyme Technologies is a research driven company with global leadership in the manufacturing of enzymes and probiotics. The company provides eco-safe solutions to a wide variety of industries like human health care and nutrition, animal nutrition, baking, fruit & vegetable processing, brewing & malting, grain processing, protein modification, dairy processing, specialty applications, textile processing and others. Its aim is to replace traditionally used chemicals with eco-friendly enzymatic solutions.

Powered by Capital Market - Live News

Net profit of Advanced Enzyme Technologies rose 31.98% to Rs 43.33 crore in the quarter ended September 2025 as against Rs 32.83 crore during the previous quarter ended September 2024. Sales rose 26.30% to Rs 184.53 crore in the quarter ended September 2025 as against Rs 146.10 crore during the previous quarter ended September 2024.

Powered by Capital Market - Live News

Advanced Enzyme Techs. will hold a meeting of the Board of Directors of the Company on 12 November 2025.

Powered by Capital Market - Live News

Advanced Enzyme Technologies has allotted 45,650 equity shares under ESOP. Consequent to the said allotment, the paid-up share capital of the Company stands increased from Rs 22,37,62,300 comprising of 11,18,81,150 equity shares of Rs 2 each to Rs 22,38,53,600 comprising of 11,19,26,800 equity shares of Rs 2 each.

Powered by Capital Market - Live News